cognitive cybersecurity intelligence

News and Analysis

Search

New patent for Blueprint Medicines drug AYVAKIT

The drug Ayvakit, marketed by Blueprint Medicines, is protected by four patents with forty patent family members in thirty-one countries. The generic ingredient in Ayvakit is avapritinib, available from one supplier. More information is available on DrugPatentWatch.

Source: www.drugpatentwatch.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts